Which adults with early breast cancer is pertuzumab (Perjeta) indicated for?

Perjeta (pertuzumab), with trastuzumab and chemotherapy, is indicated for neoadjuvant treatment of adults with HER2-positive locally advanced, inflammatory or early-stage breast cancer at high risk of recurrence, and adjuvant treatment of adults with HER2-positive early breast cancer at high risk of recurrence.